V
Virax Biolabs Group Limited D
D
VRAX
3.49000
USD
0.36
(11.50%)
Post Trading·3.37000USD-0.12000(-3.44%)
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
2,781,488
العنوان: Virax Biolabs Group Limited
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
